Abstract

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study [RAW_REF_TEXT] Heinz Reichmann1 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Andrew Lees2 , [/RAW_REF_TEXT] [RAW_REF_TEXT] José-Francisco Rocha3 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Diogo Magalhães3,5 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Patrício Soares-da-Silva 4,5,6 & [/RAW_REF_TEXT] [RAW_REF_TEXT] the OPTIPARK investigators [/RAW_REF_TEXT] Translational Neurodegeneration volume 9, Article number: 14 (2020) Cite this article [RAW_REF_TEXT] 131 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] [RAW_REF_TEXT] The original article was published in Translational Neurodegeneration 2020 9:9 [/RAW_REF_TEXT] Correction to: Correction to Fig. 2b Fig. 2 figure1 Global Impression of Change following 3 months treatment with opicapone 50 mg (a) investigator rated (CGI-C, n = 477, LOCF); (b) self-rated by the patient (PGI-C, n = 393) Full size image Rating scale outcomes Correction to UPDRS analyses (Table 2) Table 2 Rating scale assessments Full size table N numbers for UPDRS Part II were 475 at baseline and 389 at 3 months (Visit 4); results of the change from baseline analysis remain unchanged. Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study [RAW_REF_TEXT] Heinz Reichmann1 , Andrew Lees2 , José-Francisco Rocha3 , Diogo Magalhães3,5 , Patrício Soares-da-Silva 4,5,6 & the OPTIPARK investigators [/RAW_REF_TEXT] Translational Neurodegeneration volume 9, Article number: 14 (2020) Cite this article [RAW_REF_TEXT] 131 Accesses Metrics details The original article was published in Translational Neurodegeneration 2020 9:9

Details

Title
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Author
Heinz Reichmann 1 ; Lees, Andrew; José-Francisco Rocha; Magalhães, Diogo; Soares-da-Silva, Patrício

 Heinz Reichmann 
Pages
1-3
Section
Correction
Publication year
2020
Publication date
2020
Publisher
BioMed Central
e-ISSN
20479158
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2404400711
Copyright
© 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.